Disease/Infection News

RSS

In Southeast Asia, robust immunity found up to 9 months after SARS-CoV-2 infection

Now, a new study posted to the bioRxiv* preprint server focuses on functional immune memory to SARS-CoV-2, up to nine months in a Southeast Asian cohort, in the absence of re-infection.

16 Aug 2021

Vaccinating previously infected induces more potent antibodies less susceptible to escape from SARS-CoV-2 variants

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more than 4.3 million lives worldwide. Even after implementing various measures, such as vaccination and social restrictions, SARS-CoV-2 and its variants of concern (VoC) leave the world's public health systems and economies in turmoil.

16 Aug 2021

Moderna COVID-19 vaccine safe and efficacious in adolescents according to a new study

The safety, immunogenicity, and efficacy of the vaccines in adolescents are largely unknown. Now, a new study published in the New England Journal of Medicine evaluates the safety and efficacy of the mRNA-1273 vaccine in adolescents (12-17 years of age).

16 Aug 2021

Tool for defining new SARS-CoV-2 spike nucleotide sequences to Pango lineage sets

In a recent study, a group of researchers determined the degree to which Pango lineages are distinguishable using spike-only nucleotide sequences.

16 Aug 2021

Real-time genomics to track SARS-CoV-2 help contain transmission in New Zealand

A recent study discusses how New Zealand rapidly employed real-time genomics to contain new COVID-19 cases.

16 Aug 2021

Regional policies not sufficient to comprehensively tackle covid-19 infection risk, study suggests

In a new paper published in the The Lancet Regional Health - Europe, Mr Gabriele Guaitoli and Dr Roberto Pancrazi from the Department of Economics at Warwick University investigate whether region-wide non-pharmaceutical interventions introduced in Italy during the second wave of Covid-19 in Fall 2020 have been effective at eliminating local risk factors.

16 Aug 2021

Viral load could not predict transmissibility of SARS-CoV-2, study finds

The transmission of SARS-CoV-2 virus is dependent on many factors. Although some in vitro studies indicate that the amount of virus isolated from infected individuals affects the successful rate of virus transmission, whether the viral load carried at the individual level can determine transmissibility was unknown.

16 Aug 2021

Beneficial and protective effects of SARS-CoV-2 vaccines far outweigh the risk of Bell's palsy

The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.

16 Aug 2021

Local perceptions of COVID-19 risk do not correlate with the infection rate, survey finds

Superspreading events have proven to be the primary mode of infection driving the COVID-19 pandemic, which has led to an inaccurate perception of risk.

16 Aug 2021

UK shares COVID-19 vaccines with Malawi

This is the first tranche of the 100 million vaccines the Prime Minister pledged the UK would share within the next year at last month's G7 in Cornwall, 80 million of which will go to COVAX, a scheme that ensures equitable, global access to Covid-19 vaccines.

16 Aug 2021

Blood clotting markers found to be elevated in patients with Long COVID syndrome

New evidence shows that patients with Long COVID syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and fatigue.

16 Aug 2021

The newest disease detection tool for covid and beyond: Poop

Since reopening campus at the University of California-San Diego last summer, university officials have relied on the tried-and-true public health strategies of testing and contact tracing. But they have also added a new tool to their arsenal: excrement.

16 Aug 2021

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

16 Aug 2021

Response to a third SARS-CoV-2 vaccine dose amongst immunocompromised

In a research paper recently uploaded to the preprint server medRxiv* by Schrezenmeier et al. (August 12th, 2021) the potential benefit of three vaccine doses in either a homogenous or heterogeneous dosing regimen amongst kidney transplant patients is assessed, finding that the search for viable vaccination approaches amongst these patients remains an urgent medical need.

16 Aug 2021

Study reports the prevalence of different types of shock in COVID-19 patients

A new database analysis of critically ill patients with pneumonia related to COVID-19, published in the American Journal of Cardiology and conducted at Hackensack Meridian Hackensack University Medical Center (HUMC), is the first study to report the prevalence of different types of shock in patients with COVID-19.

16 Aug 2021

More than one in ten COVID-19 patients acquired the virus in a hospital during UK's first wave

More than one in ten COVID-19 patients in 314 UK hospitals caught the infection in hospital during the first pandemic wave say researchers conducting the world's largest study of severe COVID-19.

16 Aug 2021

Clinical discussions on diet-associated NAFLD and COVID-19 mortality risk among PPI users

The August issue of The American Journal of Gastroenterology includes clinical discussions of diet-associated NAFLD risk and increased risk of mortality from COVID-19 among PPI users.

16 Aug 2021

Primate study shows benefit of mRNA vaccine booster shot against SARS-CoV-2 variants

In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.

16 Aug 2021

First dose of COVID-19 vaccine to be offered to all young people aged 16 to 17 in England

All young people aged 16 to 17 in England are to be offered the first dose of a COVID-19 vaccine by Monday 23 August to give them the vital protection provided by the vaccine before returning to school in September, the Health and Social Secretary Sajid Javid has announced today (15 August).

16 Aug 2021

Cost of NHS Test and Trace tests for international arrivals to be reduced in the UK

UK holidaymakers will benefit from cheaper travel testing packages, with the price of some tests to fall by a fifth from today.

16 Aug 2021

Disease/Infection News

In Southeast Asia, robust immunity found up to 9 months after SARS-CoV-2 infection

Vaccinating previously infected induces more potent antibodies less susceptible to escape from SARS-CoV-2 variants

Moderna COVID-19 vaccine safe and efficacious in adolescents according to a new study

Tool for defining new SARS-CoV-2 spike nucleotide sequences to Pango lineage sets

Real-time genomics to track SARS-CoV-2 help contain transmission in New Zealand

Regional policies not sufficient to comprehensively tackle covid-19 infection risk, study suggests

Viral load could not predict transmissibility of SARS-CoV-2, study finds

Beneficial and protective effects of SARS-CoV-2 vaccines far outweigh the risk of Bell's palsy

Local perceptions of COVID-19 risk do not correlate with the infection rate, survey finds

UK shares COVID-19 vaccines with Malawi

Blood clotting markers found to be elevated in patients with Long COVID syndrome

The newest disease detection tool for covid and beyond: Poop

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

Response to a third SARS-CoV-2 vaccine dose amongst immunocompromised

Study reports the prevalence of different types of shock in COVID-19 patients

More than one in ten COVID-19 patients acquired the virus in a hospital during UK's first wave

Clinical discussions on diet-associated NAFLD and COVID-19 mortality risk among PPI users

Primate study shows benefit of mRNA vaccine booster shot against SARS-CoV-2 variants

First dose of COVID-19 vaccine to be offered to all young people aged 16 to 17 in England

Cost of NHS Test and Trace tests for international arrivals to be reduced in the UK

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News